Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup

Heinz Ludwig, Meletios A. Dimopoulos, Philippe Moreau, Wee Joo Chng, Hartmut Goldschmidt, Roman Hájek, Thierry Facon, Ludek Pour, Ruben Niesvizky, Albert Oriol, Laura Rosiñol, Aleksandr Suvorov, Gianluca Gaidano, Tomas Pika, Katja Weisel, Vesselina Goranova-Marinova, Antonio Palumbo, Heidi H. Gillenwater, Nehal Mohamed, Sanjay AggarwalShibao Feng, Douglas Joshua

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)2501-2504
Number of pages4
JournalLeukemia and Lymphoma
Volume58
Issue number10
DOIs
Publication statusPublished - 3 Oct 2017

Cite this